These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 37306391)
1. PGC7 regulates H3K27me3 modification by inhibiting the interaction of YY1 with PRC2. Hao W; Huang C; Liu D; Xu H; Liu Y; Guan Y; Chen B; Guo Z Am J Physiol Cell Physiol; 2023 Jul; 325(1):C286-C299. PubMed ID: 37306391 [TBL] [Abstract][Full Text] [Related]
2. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
3. Polycomb recruitment at the Class II transactivator gene. Boyd NH; Morgan JE; Greer SF Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of enhancer of zeste homolog 2 (EZH2) -Yin Yang 1 (YY1) axis in cancer. Chandnani N; Gupta I; Thakkar V; Sarkar K Pathol Res Pract; 2023 Nov; 251():154885. PubMed ID: 37862922 [TBL] [Abstract][Full Text] [Related]
5. EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance. Chu L; Tan D; Zhu M; Qu Y; Ma X; Song BL; Qi W J Biol Chem; 2023 Apr; 299(4):103073. PubMed ID: 36858198 [TBL] [Abstract][Full Text] [Related]
6. Polycomb Repressive Complex 2 in Oncology. Guo Y; Yu Y; Wang GG Cancer Treat Res; 2023; 190():273-320. PubMed ID: 38113005 [TBL] [Abstract][Full Text] [Related]
8. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation. Mu W; Starmer J; Yee D; Magnuson T Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506 [TBL] [Abstract][Full Text] [Related]
9. EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer. Chinaranagari S; Sharma P; Chaudhary J Oncotarget; 2014 Aug; 5(16):7172-82. PubMed ID: 25115397 [TBL] [Abstract][Full Text] [Related]
10. Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification. Gherardi S; Ripoche D; Mikaelian I; Chanal M; Teinturier R; Goehrig D; Cordier-Bussat M; Zhang CX; Hennino A; Bertolino P Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):427-437. PubMed ID: 28215965 [TBL] [Abstract][Full Text] [Related]
11. A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis. Guo P; Lim RC; Rajawasam K; Trinh T; Sun H; Zhang H Elife; 2024 Feb; 13():. PubMed ID: 38346162 [TBL] [Abstract][Full Text] [Related]
12. Regulation of histone methylation by automethylation of PRC2. Wang X; Long Y; Paucek RD; Gooding AR; Lee T; Burdorf RM; Cech TR Genes Dev; 2019 Oct; 33(19-20):1416-1427. PubMed ID: 31488576 [TBL] [Abstract][Full Text] [Related]
13. Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma. Lee CH; Yu JR; Granat J; Saldaña-Meyer R; Andrade J; LeRoy G; Jin Y; Lund P; Stafford JM; Garcia BA; Ueberheide B; Reinberg D Genes Dev; 2019 Oct; 33(19-20):1428-1440. PubMed ID: 31488577 [TBL] [Abstract][Full Text] [Related]
14. Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation. Rush M; Appanah R; Lee S; Lam LL; Goyal P; Lorincz MC Epigenetics; 2009 Aug; 4(6):404-14. PubMed ID: 19717977 [TBL] [Abstract][Full Text] [Related]
15. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Caretti G; Di Padova M; Micales B; Lyons GE; Sartorelli V Genes Dev; 2004 Nov; 18(21):2627-38. PubMed ID: 15520282 [TBL] [Abstract][Full Text] [Related]
16. Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylation. Kraft K; Yost KE; Murphy SE; Magg A; Long Y; Corces MR; Granja JM; Wittler L; Mundlos S; Cech TR; Boettiger AN; Chang HY Proc Natl Acad Sci U S A; 2022 May; 119(22):e2201883119. PubMed ID: 35617427 [TBL] [Abstract][Full Text] [Related]
17. The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2. Ferreira M; Verbinnen I; Fardilha M; Van Eynde A; Bollen M J Biol Chem; 2018 Nov; 293(47):18031-18039. PubMed ID: 30305391 [TBL] [Abstract][Full Text] [Related]
18. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications. Kim SH; Yang WI; Min YH; Ko YH; Yoon SO Tumour Biol; 2016 Feb; 37(2):2037-47. PubMed ID: 26337274 [TBL] [Abstract][Full Text] [Related]
19. The roles of EZH2 in cancer and its inhibitors. Liu Y; Yang Q Med Oncol; 2023 May; 40(6):167. PubMed ID: 37148376 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions. Zeng X; Chen S; Huang H Cell Cycle; 2011 Feb; 10(4):579-83. PubMed ID: 21278485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]